Image credit: Brian Shamblen

FDA: The Cannabis Regulatory Landscape is “Complex”

A policy coordinator with the FDA’s Cannabis Product Committee spoke about CBD during a Food and Drug Law Institute event focused on cannabis.

CBD
Newsletter, Regulation

Who’s Calling for a Hearing on Rescheduling?

An excerpt from the Cannabis Wire Daily newsletter.

Newsletter

From Congress to Iowa and Colorado, New Battles Brew Over Intoxicating Hemp

An excerpt from the Cannabis Wire Daily newsletter.